Basit öğe kaydını göster

dc.contributor.authorSahiner, Umit M
dc.contributor.authorBirben, Esra
dc.contributor.authorErzurum, Serpil
dc.contributor.authorSackesen, Cansin
dc.contributor.authorKalayci, Omer
dc.date.accessioned2019-12-10T10:50:00Z
dc.date.available2019-12-10T10:50:00Z
dc.date.issued2011
dc.identifier.issn1939-4551
dc.identifier.urihttps://doi.org/10.1097/WOX.0b013e318232389e
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488912/
dc.identifier.urihttp://hdl.handle.net/11655/14289
dc.description.abstractAsthma is a chronic inflammatory lung disease that results in airflow limitation, hyperreactivity, and airway remodeling. There is strong evidence that an imbalance between the reducing and oxidizing systems favoring a more oxidative state is present in asthma. Endogenous and exogenous reactive oxygen species, such as superoxide anion, hydroxyl radical, hypohalite radical, and hydrogen peroxide, and reactive nitrogen species, such as nitric oxide, peroxynitrite, and nitrite, play a major role in the airway inflammation and are determinants of asthma severity. Asthma is also associated with decreased antioxidant defenses, such as superoxide dismutase, catalase, and glutathione. In this review, we will summarize the current knowledge and discuss the current and future strategies for the modulation of oxidative stress in asthma.
dc.relation.isversionof10.1097/WOX.0b013e318232389e
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleOxidative Stress In Asthma
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalThe World Allergy Organization journal
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları
dc.identifier.volume4
dc.identifier.issue10
dc.identifier.startpage151
dc.identifier.endpage158
dc.description.indexPubMed


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster